News | Aquavit Pharmaceuticals, Inc.

Aquavit's AQV-1122 COVID-19 Vaccine Patent Approval Fast Tracked by USPTO

September 1, 2021; New York, NY Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a...

May 4, 2021; New York, NY U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for...

NEW YORK, April 14, 2021 Aquavit Holdings LLC announced today that it acquired an exclusive license to register, market and commercialize...

March 19, 2021: New York, NY Aquavit Pharmaceuticals, Inc. (“Aquavit”) announced today that the United States Patent and Trademark Office...

About Dr. Sten Vermund: Dr. Sten Vermund is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle...

April 15, 2021: New York, NY The European Union Intellectual Property Office (EUIPO) declared that U-BioMed’s falsely registered...

NEW YORK, Dec. 2, 2020 We are now living in the "new-normal" era, wearing face masks everywhere. With the extended use of face coverings,...

October 15, 2020: New York, NY Aquavit filed a new patent application with the United States Patent and Trademark Office. The patent...

September 08, 2020: New York, NY Aquavit Pharmaceuticals, Inc. ("Aquavit") won a default judgement against counterfeiter in the United...

August 18, 2020: New York, NY Aquavit Files For New COVID-19 Self-Administrable Vaccine Delivery Method and Technology Patent Through...

August 13, 2020: New York, NY Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for...

July 1, 2020; New York, NY Aquavit has filed a new patent application with the United States Patent and Trademark Office. The patent...

June 08, 2020: New York, NY Aquavit Pharmaceuticals Unveils Its Platform Technology Addressing COVID-19 at 2020 BIO International...

April 15, 2020: New York, NY New Drug Delivery Platform and Immunotherapeutic Compositions Against Cancer Using Proprietary Microchannel...

March 27, 2020: Aquavit Pharmaceuticals, Inc. Announces Filing of New Patent Applications for a New Drug Delivery Platform and Vaccine...

March 27, 2020 Aquavit filed a new patent application with the United States Patent and Trademark Office. The patent covers novel methods...

June 3, 2019: New York, NY New York-based Aquavit Pharmaceuticals, Inc. is delighted to introduce Dr. Jill Waibel as its new Chief...

June 3, 2019: New York, NY Aquavit Pharmaceuticals, Inc. announced today that Chief Executive Officer Sobin Chang will be presenting at...

Seoul, South Korea May 28, 2019 – Aquavit Life Sciences, Inc. today received an official notice from the police that they have requested...

NEW YORK, April 29, 2019 – Aquavit Pharmaceuticals, Inc. secured a Preliminary Injunction Order in the United States District Court for...